AI-Powered Simulation for a Faster, Smarter Future
GlucoLink Nexus is a next-generation simulation platform built to accelerate and de-risk diabetes technology development. It empowers device makers, clinicians, and researchers with predictive tools that simulate glucose dynamics and closed-loop insulin control—before a device ever reaches a clinical trial.
Key Capabilities
Key Capabilities– 
AI Simulation Engine – Predicts glucose-insulin responses with sub-3-minute precision
– Closed-Loop Control Testing – Validates RL-MPC and PID algorithms for insulin pumps
– Custom Scenario Modeling – Simulate meals, exercise, sensor noise, and behavior patterns
– Real-Time Dashboards – Intuitive visualizations for clinicians, engineers, and researchers
– HIPAA-Compliant Workflows – Ready for regulatory integration (ISO 13485, FDA SaaMD)
Built for Device Makers, Researchers & CROs
Built for Device Makers, Researchers & CROs– 
Faster Validation: Simulate thousands of therapy outcomes in hours.
– 
Lower Cost: Reduce dependence on animal or early-phase human trials.
– 
Scalable Delivery: SaaS-ready, API extensible, and secure.
– 
Dual Market Reach: In vivo simulation + real-world CGM integration.
Market Opportunity
Market Opportunity– Global Diabetes Device Market: $24B+ and growing
– Target Customers:
– Insulin pump + CGM manufacturers
– Digital health startups
– CROs & academic research groups